Cargando…
Barriers to receiving hepatitis C treatment for people who inject drugs: Myths and evidence
BACKGROUND: Alcohol consumption, current injecting drug use, and pre-existing mental illness have been identified as 3 of the main reasons for excluding patients from treatment for hepatitis C. OBJECTIVES: We reviewed the literature to obtain an evidence base for these common exclusion criteria. MAT...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Kowsar
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3212767/ https://www.ncbi.nlm.nih.gov/pubmed/22087188 |
_version_ | 1782216020293844992 |
---|---|
author | Higgs, Peter Sacks-Davis, Rachel Gold, Judy Hellard, Margaret |
author_facet | Higgs, Peter Sacks-Davis, Rachel Gold, Judy Hellard, Margaret |
author_sort | Higgs, Peter |
collection | PubMed |
description | BACKGROUND: Alcohol consumption, current injecting drug use, and pre-existing mental illness have been identified as 3 of the main reasons for excluding patients from treatment for hepatitis C. OBJECTIVES: We reviewed the literature to obtain an evidence base for these common exclusion criteria. MATERIALS AND METHODS: We reviewed original research and meta-analyses investigating the effects of alcohol consumption, current injecting drug use, and pre-existing mental illness. RESULTS: We identified 66 study reports relevant to the review, but found only limited evidence to support withholding of treatment on the basis of the 3 previously mentioned exclusion criteria. CONCLUSIONS: Currently, there is a lack of evidence for many of the barriers faced by patients in availing treatment for hepatitis C. Adherence to treat routine was found to be a better predictor of sustained virological response than injecting drug or alcohol consumption during treatment period or the presence of a pre-existing mental disorder. Although several challenges remain, we need to ensure that treatment decisions are based on the best available evidence and the treatment is performed appropriately on a case-by-case basis. |
format | Online Article Text |
id | pubmed-3212767 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | Kowsar |
record_format | MEDLINE/PubMed |
spelling | pubmed-32127672011-11-15 Barriers to receiving hepatitis C treatment for people who inject drugs: Myths and evidence Higgs, Peter Sacks-Davis, Rachel Gold, Judy Hellard, Margaret Hepat Mon Review Article BACKGROUND: Alcohol consumption, current injecting drug use, and pre-existing mental illness have been identified as 3 of the main reasons for excluding patients from treatment for hepatitis C. OBJECTIVES: We reviewed the literature to obtain an evidence base for these common exclusion criteria. MATERIALS AND METHODS: We reviewed original research and meta-analyses investigating the effects of alcohol consumption, current injecting drug use, and pre-existing mental illness. RESULTS: We identified 66 study reports relevant to the review, but found only limited evidence to support withholding of treatment on the basis of the 3 previously mentioned exclusion criteria. CONCLUSIONS: Currently, there is a lack of evidence for many of the barriers faced by patients in availing treatment for hepatitis C. Adherence to treat routine was found to be a better predictor of sustained virological response than injecting drug or alcohol consumption during treatment period or the presence of a pre-existing mental disorder. Although several challenges remain, we need to ensure that treatment decisions are based on the best available evidence and the treatment is performed appropriately on a case-by-case basis. Kowsar 2011-07-01 2011-07-01 /pmc/articles/PMC3212767/ /pubmed/22087188 Text en Copyright © 2011, Kowsar M.P. Co. http://creativecommons.org/licenses/by/2.5/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Article Higgs, Peter Sacks-Davis, Rachel Gold, Judy Hellard, Margaret Barriers to receiving hepatitis C treatment for people who inject drugs: Myths and evidence |
title | Barriers to receiving hepatitis C treatment for people who inject drugs: Myths and evidence |
title_full | Barriers to receiving hepatitis C treatment for people who inject drugs: Myths and evidence |
title_fullStr | Barriers to receiving hepatitis C treatment for people who inject drugs: Myths and evidence |
title_full_unstemmed | Barriers to receiving hepatitis C treatment for people who inject drugs: Myths and evidence |
title_short | Barriers to receiving hepatitis C treatment for people who inject drugs: Myths and evidence |
title_sort | barriers to receiving hepatitis c treatment for people who inject drugs: myths and evidence |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3212767/ https://www.ncbi.nlm.nih.gov/pubmed/22087188 |
work_keys_str_mv | AT higgspeter barrierstoreceivinghepatitisctreatmentforpeoplewhoinjectdrugsmythsandevidence AT sacksdavisrachel barrierstoreceivinghepatitisctreatmentforpeoplewhoinjectdrugsmythsandevidence AT goldjudy barrierstoreceivinghepatitisctreatmentforpeoplewhoinjectdrugsmythsandevidence AT hellardmargaret barrierstoreceivinghepatitisctreatmentforpeoplewhoinjectdrugsmythsandevidence |